000 01500 a2200373 4500
005 20250513102550.0
264 0 _c19970103
008 199701s 0 0 eng d
022 _a0022-510X
024 7 _a10.1016/0022-510x(96)00028-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDuggan, D J
245 0 0 _aalpha-Sarcoglycan (adhalin) deficiency: complete deficiency patients are 5% of childhood-onset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutations.
_h[electronic resource]
260 _bJournal of the neurological sciences
_cSep 1996
300 _a30-9 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aBase Sequence
650 0 4 _aCytoskeletal Proteins
_xanalysis
650 0 4 _aDystrophin
_xgenetics
650 0 4 _aHumans
650 0 4 _aImmunoblotting
650 0 4 _aMembrane Glycoproteins
_xanalysis
650 0 4 _aMolecular Sequence Data
650 0 4 _aMuscular Dystrophies
_xgenetics
650 0 4 _aMutation
650 0 4 _aRNA, Messenger
_xmetabolism
650 0 4 _aSarcoglycans
700 1 _aFanin, M
700 1 _aPegoraro, E
700 1 _aAngelini, C
700 1 _aHoffman, E P
773 0 _tJournal of the neurological sciences
_gvol. 140
_gno. 1-2
_gp. 30-9
856 4 0 _uhttps://doi.org/10.1016/0022-510x(96)00028-7
_zAvailable from publisher's website
999 _c8859214
_d8859214